Keywords: NAD +; ADMA; asymmetric dimethylarginine; cAMP; cyclic AMP; CVD; cardiovascular disease; CT; chemotherapy; DOX; doxorubicin; DDAH; dimethylarginine diaminohydrolase; eNOS; endothelial nitric oxide synthase; FSK; forskolin; HCY; homocysteine; HTRF; homogenous tim
مقالات ISI NAD + (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: NAD +; BMAL1; brain and muscle ARNT-like 1; CCG; clock-controlled genes; CLOCK; circadian locomoter output cycles protein kaput; CRY; Cryptochrome; KO; knock-out; NAD+; nicotinamide adenine dinucleotide (oxidized); NADH; nicotinamide adenine dinucleotide (reduce
Keywords: NAD +; CVDs; cardiovascular diseases; ECs; endothelial cells; VSMCs; vascular smooth muscle cells; HPTMs; histones post-translational modifications; nt; nucleotides; 5-mC; 5-methylcytosine; 5-hmC; 5-hydroxymethylcytosine; CpG; sequence of cytosine followed by a
Keywords: NAD +; Nicotinamide adenine dinucleotide; Nicotinamide phosphoribosyl transferase; High fat feeding; Mitochondrial gene expression; Insulin sensitivity; Exercise; CD; chow diet; HFD; 45% high fat diet; LFD; 10% low fat diet; Mck; muscle creatine kinase; NAD+; ni
Keywords: NAD +; T2DM; Type 2 diabetes mellitus; NG; normal glucose concentration; HG; high glucose concentration; mTORC; mammalian target of rapamycin complex; GLUT; glucose transporters; LKB1; Liver kinase B1; AMPK; AMP-activated protein kinase; AKT; Protein kinase B; A
Keywords: NAD +; KP; kynurenine pathway; IDO; indoleamine 2,3-dioxygenase; TDO2; tryptophan 2,3 dioxygenase (gene); TDO; tryptophan 2,3 dioxygenase (enzyme); KAT; kynurenine aminotransferase; KMO; kynurenine monooxigenase; Trp; tryptophan; KYN; L-kynurenine; KYNA; kynuren
Keywords: NAD +; Parkinson's disease; Ghrelin; Dementia; AHN; adult hippocampal neurogenesis; AD; Alzheimer's Disease; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; AMPK; AMP-activated protein kinase; AB; amyloid-β; ATG; autophagy-related; BBB; blood brain
Keywords: NAD +; Doxorubicin-induced cardiomyopathy; Stem-cell transplantation; Resveratrol; Mitochondrial delivery; MITO-porter; MITO cell; OXPHOS; oxidative phosphorylation; CPC; Cardiac progenitor cell; NAD+; Â nicotinamide adenine dinucleotide; Sirt1; sirtuine1; PGC1Î
Keywords: NAD +; Skeletal muscle; NAD+; Energy metabolism; Nicotinamide riboside;
Keywords: NAD +; 3-HK; 3-hydroxykynurenine; 6-OHDA; 6-hydroxydopamine; A; Amygdala; ACMSD; 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase; AD; Alzheimer's disease; AD; Anterodorsal nucleus (Thalamus); α-syn; Alpha-synuclein; CCL2; Chemokine (CC motif) ligand 2;
Glycation inhibitors extend yeast chronological lifespan by reducing advanced glycation end products and by back regulation of proteins involved in mitochondrial respiration
Keywords: NAD +; AGEs; advanced glycation end products; CR; calorie restriction; NR; non-calorie restriction; CLS; chronological lifespan; AMG; aminoguanidine; MET; metformin; HYD; hydralazine; RLS; replicative lifespan; Sch9, threonine/threonine; protein kinase; TOR; Tar
Keywords: NAD +; DCA; Dichloroacetate; ECAR; extra cellular acidification rate; JC-1; 5,5â²,6,6â²-tetrachloro-1,1â²,3,3â²-tetraethylbenzimidazolycarbocyanine; MMP; ÎÏm, mitochondrial membrane potential; NAD+; Â nicotinamide adenine dinucleotide; NADH; reduced nicoti
Keywords: NAD +; ATP; adenosine triphosphate; BrP; bromopyruvate; CO2; carbon dioxide; CoA; acetyl-coenzyme A; 2-DG; 2-deoxyglucose; ETC; electron transport chain; FAO; fatty acid oxidation; FAD; flavin adenine dinucleotide; FDG; fluorinated deoxyglucose; FFA; free fatty
Keywords: NAD +; ACL; ATP citrate lyase; Akt; Protein kinase B; ASCT2; Alanine, serine, cysteine-preferring transporter 2; ASS; Argininosuccinate synthetase; BMI; Body mass index; CAF; Cancer-associated fibroblasts; ER; Estrogen receptor; FASN; Fatty acid synthase; GPC; G
Keywords: NAD +; AMPA; α-amino3-hydroxy-5-methyl-4-isoxazolepropionic acid; BBB; Blood brain barrier; BCAO; Bilateral ligation of common carotid arteries; CAT; Catalase; CBF; Cerebral blood flow; CCA; Common carotid artery; CNS; Central nervous system; COX-2; Cyclooxygen
Keywords: NAD +; Glutamate oxidase; Glutamate dehydrogenase; Monosodium glutamate; Amperometry; Carbon nanotubes; Reagentless; Biosensor; NADH; NAD+; Differential pulse voltammetry
Keywords: NAD +; AcHz; acetylhydrazine; AcINH; acetylisoniazid; ALP; alkaline phosphatase; ALT; alanine aminotransferase; DiAcHz; diacetylhydrazine; GSH; glutathione; GST; glutathione S-transferase; Hz; hydrazine; INA; isonicotinic acid; INH; isoniazid; MPO; myeloperoxida
Keywords: NAD +; cardiopulmonary resuscitation; sepsis; septic shock; shock; ATP; adenosine triphosphate; NADH; nicotinamide adenine dinucleotide hydride; NAD+; oxidized form of nicotinamide adenine dinucleotide; Na+-K+-ATPase; sodium-potassium-adenosine triphosphatase; R
Keywords: NAD +; DOX; doxorubicin; Sirt6; sirtuin6; HDAC; histone deacetylase; FPG; formamidopyrimidine DNA glycosylase; EndoIII; endonuclease III; PARP; poly-ADP-ribose polymerase; NAD+; nicotinamide adenine dinucleotide; SOD; superoxide dismutase; ROS; reactive oxygen s
Keywords: NAD +; High-fat; Non-alcoholic liver disease; Obesity; Scopoletin; Transcriptome; ALT; alanine aminotransferase; Apoa4; apolipoprotein A-IV; AST; aspartate aminotransferase; β-oxidation; fatty acid β-oxidation; Cdkn1a; cyclin-dependent kinase inhibitor 1A; Cid
Keywords: NAD +; APDS; aminoethylpyridyldisulfide; APS; ammonium persulfate; ASP; apple stem pitting virus; AuNR; gold nanorod; BIS; N,N-methylenebisacrylamide; BSA; bovine serum albumin; BHb; bovine hemoglobin; CD; cyclodextrin; CNT; carbon nanotube; CV; cyclic voltammet
Keywords: NAD +; GAPDH; Protein aggregation; Inhibitor; Cell death; Therapeutics; ANOVA; one-way analysis of variance; DMEM/F12; Dulbecco's modified Eagle medium/Ham's F12; EDTA; ethylenediaminetetraacetic acid; GAI; GAPDH aggregation inhibitor; GAP; glyceraldehyde-3-phos
Keywords: NAD +; Glycerophosphate shuttle; Glycolysis; AMPK; BALB/cHeA mice; AICAR; 5-aminoimidazole-4-carboxamide-1-b-d-ribofuranoside; AMPK; AMP activated protein kinase; AMP; adenosine monophosphate; ATP; adenosine triphosphate; By; BALB/cBy; COX2; cytochrome c oxidase
Keywords: NAD +; HAT; HDAC; acetyl-CoA; NAD+; metabolism; gene expression;
Keywords: NAD +; IgG; immunoglobulin G; ATP; adenosine triphosphate; NAD+; nicotinamide adenine dinucleotide; CNBr; cyanogens bromide; PNGase F; peptide N-glycosidase F; BHI; Brain-Heart Infusion; ANTS; 8-aminonaphthalene-1,3,6-trisulfonate; BCIP; 5-Bromo 4-Chloro 3â²
Keywords: NAD +; NAD+; nicotinamide adenine dinucleotide; SIRT; sirtuin; PARP; poly(ADP-ribose) polymerase; OHCs; outer hair cells; ROS; reactive oxygen species; NOX; NAD(P)H oxidases; TNF; tumor necrosis factor; RANTES; regulated on activation normal T-cell expressed and
Keywords: NAD +; GnRH neurons; Kisspeptin neurons; Female puberty; Chromatin modifications; DNA methylation; Transcriptional repression; Transcriptional activation; Epigenetic regulators; microRNAs; Long noncoding RNAs; 5hmC; 5-hydroxymethylcytosine; 5-mC; 5-methylcytosin
Keywords: NAD +; A. mylitta; Antheraea mylitta; AA; amino acid; aP2; adipocyte fatty acid-binding; ASC; human-derived adipose stem cells; B. mori; Bombyx mori; BMSC; bone marrow stem cells; BSA; bovine serum albumin; Da; Dalton; DMSO; dimethyl sulfoxide; ECM; extracellula
Keywords: NAD +; Fluorescence methods; Quantum dots; Glutamate dehydrogenase; NAD+; Hepatotoxicity
Keywords: NAD +; ChREBP; carbohydrate response element-binding protein; DGAT; acyl-CoA:diacylglycerol acyltransferase; DHAP; dehydroxyacetone phosphate; FAS; fatty acid synthase; Foxo1; forkhead box O1; GAPDH; glyceraldehyde-3-phosphate dehydrogenase; GPD1; glycerol-3-pho
Keywords: NAD +; NPMDS; Newcastle Pediatric Mitochondrial Disease Scale; GMFM-88; Gross Motor Function Measure with 88 items; JMDRS; Japanese Mitochondrial Disease Rating Scale; OXPHOS; Oxidative phosphorylation; MELAS; Mitochondrial myopathy, encephalopathy, lactic acido
Keywords: NAD +; TrpDH, l-Trp dehydrogenase; NpTrpDH, NAD+-dependent l-tryptophan dehydrogenase from Nostoc punctiforme NIES-2108l-Tryptophan dehydrogenase; NAD+; Nostoc punctiforme; Amino acid dehydrogenase; B-type stereospecificity
Keywords: NAD +; DTT; dithiothreitol [(2S,3S)-1,4-bissulfanylbutane-2,3-diol]; PMSF; phenylmethylsulfonyl fluoride; Tris; 2-amino-2-hydroxymethyl-propane-1,3-diol; IPTG; isopropyl Ï-d-1-thiogalactopyranoside; EDTA; 2-[2-[bis(carboxymethyl)-amino] ethyl-(carboxymethyl)ami
Keywords: NAD +; ACADl; acyl-CoA dehydrogenase, long chain; ACADm; acyl-CoA dehydrogenase, medium chain; ACADvl; acyl-CoA dehydrogenase, very long chain; AMPK; 5â² AMP-activated protein kinase; CD36; cluster of differentiation 36; CPT2; carnitine palmitoyltransferase II;
Keywords: NAD +; AceCS2; acetyl-CoA synthetase 2; ADP; adenosine diphosphate; CPS1; carbamoyl phosphate synthetase 1; CPT1; carnitine palmitoyltransferase I; CR; calorie restriction; FOXO3a; forkhead box 03a; GDH; glutamate dehydrogenase; HeLa; human cervical carcinoma ce
Keywords: NAD +; VO2max; maximal aerobic capacity; TCA cycle; tricarboxylic acid cycle; NAD+; nicotinamide adenine dinucleotide; FAD; flavin adenine dinucleotide; FFAs; free-fatty acids; ATP; adenosine triphosphate; ADP; adenosine diphosphate; PGC-1α; peroxisome prolifer
Keywords: NAD +; 1AA; 1-aminoanthracene; CAT; carnitine acetyltransferase; CE; capillary electrophoresis; CSP; chiral stationary phase; CV; coefficient of variation; CZE; capillary zone electrophoresis; DM; dry matter; DTNB; 5,5â²-dithiobis-2-nitrobenzoate; EDAC; 1-ethyl
Keywords: NAD +; ADP; adenosine diphosphate; ALT; alanine aminotransferase; ATP; adenine triphosphate; CoA; coenzyme A; FAD; flavin adenine dinucleotide; FADH2; reduced flavin adenine dinucleotide; GPT; glutamate pyruvate transaminase; HIV; human immunodeficiency virus; L
Keywords: NAD +; Aβ; amyloid beta; AD; Alzheimer's disease; AICD; APP intracellular domain; AMPA; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; APP; amyloid β precursor protein; Apo E; apolipoprotein E; BACE1; β-site APP converting enzyme 1; BDNF; brain derive
Keywords: NAD +; Multiple Sclerosis; NAD+; NADH; Nicotinamide;
Keywords: NAD +; Autism; ATP; Oxidative stress; NAD+; Antioxidants;
Keywords: NAD +; 7-OHC; 7-hydroxycoumarin; 7-OHCG; 7-hydroxycoumarin glucuronide; AA; antimycin A; ciPTEC; conditionally immortalized human renal proximal tubule epithelial cells; CKD; chronic kidney disease; CMPF; 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid; CRF; c
Keywords: NAD +; Cyt c; cytochrome c; CYP2E1; cytochrome P4502E1; NAD+; nicotinamide-adenine dinucleotide; NADH; reduced form of nicotinamide-adenine dinucleotide; GSH; glutathione; SOD2; manganese superoxide dismutase; CAT; catalase; GSH-PX; glutathione peroxidase; MRC I
Keywords: NAD +; 3-HB; 3-Hydroxybutyrate; ALP; alkaline phosphatase; ALT; alanine aminotransferase; APAP; acetaminophen; AST; aspartate aminotransferase; ATP; adenosine-5â²-triphosphate; CHOL; cholesterol; CTRL; control; CYP450; cytochrome P450; GGT; γ-glutamyl transfer
Keywords: NAD +; NAD+; Nicotinamide; Mitochondria; DLP1; Autophagy; Lysosome; 3xTgAD; p-Akt; CREB; Learning and memory;
Keywords: NAD +; Obesity; Oxidative stress; Redox status; NAD+; Nitroxide
Keywords: NAD +; FK866; NQO1-targeting agents; Synergy; NAD+; SIRT1
Predicting the high concentration co-solvent influence on the reaction equilibria of the ADH-catalyzed reduction of acetophenone
Keywords: NAD +; ACP; acetophenone; ADH; alcohol dehydrogenase; ARD; average relative deviation; NADH; nicotinamide adenine dinucleotide in its protonated form; NAD+; nicotinamide adenine dinucleotide in its deprotonated form; 1-PE; 1-phenylethanol; PEG; polyethylene glyc
The role of SIRT1 in diabetic retinopathy
Keywords: NAD +; SIR2; Silent Information Regulator2; HDACs; histone deacetylaser; NAD+; nicotinamide adenine dinucleotide; DM; diabetes mellitus); AGEs; advanced glycation end products; AMPK; adenosine monophosphate-activated protein kinas; TGFβ1; transforming growth fa
Molecular mechanism for the inhibition of DXO by adenosine 3â²,5â²-bisphosphate
Keywords: NAD +; 5â²-3â² exoribonuclease; DXO; Adenosine 3â²,5â²-bisphosphate; Crystal; Nuclease inhibitor; DXO; decapping and exoribonuclease protein; NAD+; nicotinamide dinucleotide; NMN; nicotinamide mononucleotide; m7GDP; 7-methylguanosine diphosphate; pAp; 3â²,